| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 75.01B | 69.50B | 58.97B | 68.46B | 55.76B | 42.21B |
| Gross Profit | 28.31B | 25.97B | 20.57B | 28.41B | 23.08B | 16.35B |
| EBITDA | 28.44B | 24.71B | 19.29B | 24.42B | 20.17B | 14.76B |
| Net Income | 13.14B | 11.62B | 8.34B | 14.13B | 10.89B | 6.81B |
Balance Sheet | ||||||
| Total Assets | 149.42B | 141.50B | 133.74B | 113.53B | 92.01B | 76.03B |
| Cash, Cash Equivalents and Short-Term Investments | 36.73B | 31.30B | 31.47B | 23.41B | 24.36B | 25.71B |
| Total Debt | 18.00B | 20.07B | 20.01B | 24.82M | 19.77M | 21.87M |
| Total Liabilities | 36.28B | 37.45B | 38.72B | 26.03B | 16.71B | 9.86B |
| Stockholders Equity | 113.14B | 104.05B | 95.03B | 87.50B | 75.30B | 66.17B |
Cash Flow | ||||||
| Free Cash Flow | 18.12B | 4.38B | -7.87B | 498.10M | 973.26M | 11.00B |
| Operating Cash Flow | 21.78B | 22.73B | 7.08B | 13.93B | 10.20B | 12.82B |
| Investing Cash Flow | -8.85B | -20.57B | -18.60B | -13.42B | -9.38B | -2.62B |
| Financing Cash Flow | -4.80B | -2.41B | 17.66B | -2.12B | -2.88B | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥318.48B | 14.74 | ― | 1.23% | 8.80% | 33.39% | |
75 Outperform | ¥857.06B | 14.76 | 19.69% | 3.15% | 10.06% | 18.03% | |
74 Outperform | ¥202.44B | 8.69 | ― | 4.09% | 1.69% | 0.94% | |
69 Neutral | ¥337.36B | 10.96 | ― | 5.28% | -0.47% | 25.41% | |
66 Neutral | ¥760.52B | 10.74 | 4.79% | 4.21% | -1.21% | -27.21% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥324.97B | 36.21 | -4.00% | 3.71% | 0.24% | -234.36% |